| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Camm AJ | |
| Katritsis D | |||
| P2860 | cites work | The effect of amiodarone, a new anti-anginal drug, on cardiac muscle | Q24669966 |
| Class 1 antiarrhythmic drugs--characteristic electrocardiographic differences when assessed by atrial and ventricular pacing | Q28272594 | ||
| Conduction velocity depression and drug-induced ventricular tachyarrhythmias. Effects of lidocaine in the intact canine heart | Q28330267 | ||
| Relationship between an arrhythmogenic action of lidocaine and its effects on excitation patterns in acutely ischemic porcine myocardium | Q28336692 | ||
| Cellular electrophysiology of the new antiarrhythmic agent recainam (Wy-42,362) in canine cardiac Purkinje fibers | Q28338034 | ||
| Differential Analysis of the Frequency-Dependent Effects of Class 1 Antiarrhythmic Drugs According to Periodical Ligand Binding | Q29395490 | ||
| A Classification of Antiarrhythmic Actions Reassessed After a Decade of New Drugs | Q34248170 | ||
| Recent antiarrhythmic drugs | Q34514439 | ||
| Length of excitation wave and susceptibility to reentrant atrial arrhythmias in normal conscious dogs | Q34687432 | ||
| Kinetics of onset of rate-dependent effects of Class I antiarrhythmic drugs are important in determining their effects on refractoriness in guinea-pig ventricle, and provide a theoretical basis for their subclassification | Q34713819 | ||
| Cardiac actions in the dog of a new antagonist of adrenergic excitation which does not produce competitive blockade of adrenoceptors | Q35225966 | ||
| Significance of classifying antiarrhythmic actions since the cardiac arrhythmia suppression trial | Q37326986 | ||
| Is there chaos in cardiology? | Q38474287 | ||
| Cardiac electrophysiology: promises and contributions | Q38614703 | ||
| Mechanisms and risk factors for proarrhythmia with type Ia compared with Ic antiarrhythmic drug therapy | Q38695080 | ||
| Time- and voltage-dependent interactions of antiarrhythmic drugs with cardiac sodium channels | Q39707961 | ||
| Drug therapy. Flecainide | Q39734380 | ||
| Antiarrhythmic drug action. Blockade of the inward sodium current | Q40077780 | ||
| Quinidine delays IK activation in guinea pig ventricular myocytes | Q41252524 | ||
| Antiarrhythmic drug classification: new science and practical applications | Q41856633 | ||
| Validity of Vmax as a measure of the sodium current in cardiac and nervous tissues | Q42420303 | ||
| Mechanisms of depressed conduction from long-term amiodarone therapy in canine myocardium | Q43707389 | ||
| Frequency-dependent effects of quinidine on the ventricular action potential and QRS duration in humans | Q43788512 | ||
| Effects of flecainide on the electrophysiologic properties of isolated canine and rabbit myocardial fibers | Q44038648 | ||
| Efficacy of propafenone in preventing ventricular tachycardia: inverse correlation with rate-related prolongation of conduction time | Q46090068 | ||
| Use-dependent effects of amiodarone on Vmax in cardiac Purkinje and ventricular muscle fibers | Q46294164 | ||
| The effects of antiarrhythmic drugs, stimulation frequency, and potassium-induced resting membrane potential changes on conduction velocity and dV/dtmax in guinea pig myocardium | Q46322717 | ||
| Test of a model of antiarrhythmic drug action. Effects of quinidine and lidocaine on myocardial conduction | Q46480394 | ||
| A fourth class of anti-dysrhythmic action? Effect of verapamil on ouabain toxicity, on atrial and ventricular intracellular potentials, and on other features of cardiac function | Q46536654 | ||
| Block of inactivated sodium channels and of depolarization-induced automaticity in guinea pig papillary muscle by amiodarone | Q46989385 | ||
| Antiarrhythmic agents: modulated receptor applications. | Q51794509 | ||
| Action potential prolongation and induction of abnormal automaticity by low quinidine concentrations in canine Purkinje fibers. Relationship to potassium and cycle length. | Q51826068 | ||
| The effects of lidocaine on intracellular and extracellular potentials, activation, and ventricular arrhythmias during acute regional ischemia in the isolated porcine heart | Q51866016 | ||
| Combined effects of rate membrane potential, and drugs on maximum rate of rise (Vmax) of action potential upstroke of guinea pig papillary muscle | Q52712422 | ||
| Effect of lidocaine and quinidine on steady-state characteristics and recovery kinetics of (dV/dt)max in guinea pig ventricular myocardium | Q52716758 | ||
| Effects of quinidine on plateau currents of guinea-pig ventricular myocytes. | Q53885938 | ||
| d-Sotalol: a new potent class III anti-arrhythmic agent. | Q54151940 | ||
| Cellular electrophysiological effects of flecainide on human atrial fibres | Q67294226 | ||
| Nonuniform recovery of excitability in the left ventricle | Q67969203 | ||
| Experimental models of reentry, antiarrhythmic, and proarrhythmic actions of drugs. Complexities galore! | Q68004644 | ||
| Effects of flecainide on atrial electrophysiology in the Wolff-Parkinson-White syndrome | Q68025036 | ||
| Effects of flecainide and quinidine on human atrial action potentials. Role of rate-dependence and comparison with guinea pig, rabbit, and dog tissues | Q68339875 | ||
| Class III antiarrhythmic agents have a lot of potential but a long way to go. Reduced effectiveness and dangers of reverse use dependence | Q68447410 | ||
| Effects of amiodarone and its metabolite, desethylamiodarone, on the electrophysiologic properties of isolated cardiac muscle | Q68955965 | ||
| Antiarrhythmic uncoupling | Q69022615 | ||
| Frequency-dependent effects of amiodarone on atrioventricular nodal function and slow-channel action potentials: evidence for calcium channel-blocking activity | Q69122924 | ||
| Electrophysiologic effects and efficacy of recainam for sustained ventricular tachycardia | Q69481203 | ||
| The effects of procainamide on conduction in anisotropic canine ventricular myocardium | Q69588230 | ||
| Effects of encainide, flecainide, imipramine and moricizine on ventricular arrhythmias during the year after acute myocardial infarction: the CAPS | Q69914018 | ||
| Rate-related electrophysiologic effects of long-term administration of amiodarone on canine ventricular myocardium in vivo | Q69962160 | ||
| A consideration of antiarrhythmic therapy | Q69963848 | ||
| Acute effects of amiodarone on the electrophysiologic properties of isolated neonatal and adult cardiac fibers | Q70090791 | ||
| Aggravation and provocation of ventricular arrhythmias by antiarrhythmic drugs | Q72664804 | ||
| The effect of the cardiac membrane potential on the rapid availability of the sodium-carrying system | Q78588680 | ||
| Chemosensitivity of cardiac muscle | Q80319114 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 142-148 | |
| P577 | publication date | 1994-03-01 | |
| P1433 | published in | Clinical Cardiology | Q4502312 |
| P1476 | title | Antiarrhythmic drug classifications and the clinician: a gambit in the land of chaos | |
| P478 | volume | 17 |
Search more.